Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
genentech
3
×
life sciences
national blog main
national top stories
roche
san francisco top stories
avapritinib
blueprint medicines
boston
boston blog main
boston top stories
clinical trials
eli lilly
europe top stories
fda
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
san francisco blog main
selpercatinib
thyroid cancer
billy dunn
biogen
cancer
cancer drugs
capmatinib
cstone pharmaceuticals
deals
drug prices
drug pricing
europe blog main
european medicines agency
evrysdi
fisogatinib
flatiron health
gastrointestinal stromal tumors
gene therapy
hepatocellular carcinoma
What
drug
3
×
fda
3
×
approval
blueprint
cancer
medicines
ret
roche
therapy
address
approved
approves
atrophy
candidate
carries
certain
currently
daily
designed
evrysdi
friday
genetic
green
home
intended
latest
lights
liquid
marketing
medicine
muscle
muscular
new
oral
pact
pass
patients
regulatory
review
risdiplam
Language
unset
3
×
Current search:
fda
×
genentech
×
unset
×
drug
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact